| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |